Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial

JOURNAL ARTICLE published July 2009 in Leukemia

Authors: C B Reeder | D E Reece | V Kukreti | C Chen | S Trudel | J Hentz | B Noble | N A Pirooz | J E Spong | J G Piza | V H J Zepeda | J R Mikhael | J F Leis | P L Bergsagel | R Fonseca | A K Stewart